Table 5.

Details of adverse events or reactions with a frequency of greater than 5%

	Ketamine group (n=33)	Saline group (n=37)
Infections and infestations	3 (9%)	0
Musculoskeletal and connective tissue disorders	2 (6%)	0
Nervous system disorders	2 (6%)	1 (3%)
Psychiatric disorders	5 (15%)	7 (19%)
Skin and subcutaneous tissue disorders	2 (6%)	0

Data are n (%). Patients experiencing more than one occurrence of an adverse event in a system organ class (as defined in the Medical Dictionary for Regulatory Activities [MedDRA]) are counted once. Values include serious adverse events and adverse reactions.